Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

Post by Vimon66on Aug 12, 2017 1:40am

161 Views

Post# 26573909

Very good quarter

If There ever were any good reasons for this stock to go higher, I believe that the direction taken by the new CEO (American expansion and addition of more value added crossdeals) and the latest financial results should soon trigger some positive momentum. In any event, it certainly helps increase the potential value of NPC in a yet to materialize buyout offer.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects